{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:18:43Z","timestamp":1787750323067,"version":"build-2784847793"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>With the increasing prevalence of cardiovascular diseases, it has become common for patients to be on different classes of anticoagulant medications. The blood-thinning characteristic of these drugs makes them essential for the management of long-term comorbidities, but it also raises the possibility of hemorrhagic complications during and after ophthalmic surgery. Although there is some agreement regarding the preoperative use of anticoagulant drugs in cataract surgery, little is known about the continuation or discontinuation of these drugs before surgeries for glaucoma. Regarding the use of anticoagulants before glaucoma surgery, surgeons\u2019 practices differ greatly. Anticoagulation therapy must be understood in the context of glaucoma surgery and laser treatment, as the evidence currently available is inconclusive regarding the benefits of continuing\/withholding anticoagulation or using bridging therapy. Modifying anticoagulation therapy for glaucoma surgery must be done carefully and after consulting primary care physicians, internists, cardiologists, and neurologists due to the potential serious adverse effects of stopping the treatment.<\/jats:p>","DOI":"10.4103\/ojo.ojo_215_24","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:00:14Z","timestamp":1782266414000},"page":"174-182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Antiplatelets and anticoagulants in glaucoma surgery and laser"],"prefix":"10.4103","volume":"19","author":[{"given":"Hemlata","family":"Udenia","sequence":"first","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Bairagi","sequence":"additional","affiliation":[{"name":"Department of Ocular Anaesthesia, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewang","family":"Angmo","sequence":"additional","affiliation":[{"name":"Glaucoma Research and Clinical Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Beri","sequence":"additional","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Siddharthan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Ocular Anaesthesia, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Sharma","sequence":"additional","affiliation":[{"name":"Cataract and Refractive Surgery Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuj","family":"Dada","sequence":"additional","affiliation":[{"name":"Glaucoma Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"R1-20260624","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","article-title":"National trends in ambulatory oral anticoagulant use","volume":"128","author":"Barnes","year":"2015","journal-title":"Am J Med"},{"key":"R2-20260624","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0161-6420(03)00785-1","article-title":"Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery","volume":"110","author":"Katz","year":"2003","journal-title":"Ophthalmology"},{"key":"R3-20260624","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/EJA.0b013e328360c442","article-title":"Management of antithrombotic therapies in patients scheduled for eye surgery","volume":"30","author":"Bonhomme","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"R4-20260624","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.72.6.1177","article-title":"Clinical pharmacology of platelet cyclooxygenase inhibition","volume":"72","author":"Patrono","year":"1985","journal-title":"Circulation"},{"key":"R5-20260624","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2019.02.080","article-title":"Antithrombotics: From aspirin to DOACs in coronary artery disease and atrial fibrillation (part 3\/5)","volume":"74","author":"Verheugt","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R6-20260624","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nec.2018.06.005","article-title":"Reversal of systemic anticoagulants and antiplatelet therapeutics","volume":"29","author":"Dornbos","year":"2018","journal-title":"Neurosurg Clin N Am"},{"key":"R7-20260624","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the Vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"R8-20260624","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1055\/s-0038-1646904","article-title":"The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients","volume":"62","author":"Xi","year":"1989","journal-title":"Thromb Haemost"},{"key":"R9-20260624","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/ALN.0b013e3181ca6cfc","article-title":"Factor VII levels and international normalized ratios in the early phase of warfarin therapy","volume":"112","author":"Benzon","year":"2010","journal-title":"Anesthesiology"},{"key":"R10-20260624","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0049-3848(85)90244-0","article-title":"Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration","volume":"39","author":"Bara","year":"1985","journal-title":"Thromb Res"},{"key":"R11-20260624","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1213\/00000539-199710000-00031","article-title":"Low molecular weight heparin: Biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management","volume":"85","author":"Horlocker","year":"1997","journal-title":"Anesth Analg"},{"key":"R12-20260624","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"R13-20260624","first-page":"233","article-title":"The medical research council's general practice research framework","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"R14-20260624","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R15-20260624","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-20260624","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/eurheartj\/12.11.1225","article-title":"Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients","volume":"12","author":"Grip","year":"1991","journal-title":"Eur Heart J"},{"key":"R17-20260624","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00003088-199630040-00003","article-title":"Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations","volume":"30","author":"Palareti","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"R18-20260624","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/cs0890205","article-title":"Fibrin D-dimer: A useful clinical marker of thrombogenesis?","volume":"89","author":"Lip","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"R19-20260624","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of thromboembolism with short-term interruption of warfarin therapy","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Intern Med"},{"key":"R20-20260624","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"R21-20260624","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.10-2436","article-title":"Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: Implications of undertreatment and overtreatment in real-life clinical practice;the Loire valley atrial fibrillation project","volume":"140","author":"Gorin","year":"2011","journal-title":"Chest"},{"key":"R22-20260624","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"R23-20260624","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"R24-20260624","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (anticoagulation and risk factors in atrial fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R25-20260624","first-page":"125","article-title":"Focused 2012 update of the Canadian cardiovascular society atrial fibrillation guidelines: Recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"key":"R26-20260624","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"R27-20260624","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"R28-20260624","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the heart rhythm society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"R29-20260624","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.aorn.2012.01.018","article-title":"Anticoagulation management in the ambulatory surgical setting","volume":"95","author":"Eisenstein","year":"2012","journal-title":"AORN J"},{"key":"R30-20260624","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00101-018-0463-0","article-title":"Bridging anticoagulation in patients receiving Vitamin K antagonists: Current status","volume":"67","author":"Schellong","year":"2018","journal-title":"Anaesthesist"},{"key":"R31-20260624","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00347-009-2088-9","article-title":"Perioperative conversion of oral anticoagulants to heparin (bridging) in ophthalmic medicine","volume":"107","author":"Feltgen","year":"2010","journal-title":"Ophthalmologe"},{"key":"R32-20260624","first-page":"556","article-title":"Management of patients with prosthetic heart valves during non-cardiac surgery","volume":"61","author":"Prendergast","year":"2004","journal-title":"Przegl Lek"},{"key":"R33-20260624","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.thorsurg.2015.04.005","article-title":"Coagulopathy and anticoagulation during thoracic surgery","volume":"25","author":"Thomas","year":"2015","journal-title":"Thorac Surg Clin"},{"key":"R34-20260624","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/eye.1989.47","article-title":"Delayed suprachoroidal haemorrhage after glaucoma operations","volume":"3","author":"Canning","year":"1989","journal-title":"Eye (Lond)"},{"key":"R35-20260624","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bjo.2008.141689","article-title":"Risk factors for delayed suprachoroidal haemorrhage following glaucoma surgery","volume":"92","author":"Jeganathan","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R36-20260624","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0161-6420(01)00763-1","article-title":"Delayed suprachoroidal hemorrhage after glaucoma filtration procedures1 1the authors have no financial or proprietary interest in any aspect of this study","volume":"108","author":"Tuli","year":"2001","journal-title":"Ophthalmology"},{"key":"R37-20260624","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.eye.6702277","article-title":"The effect of aspirin and warfarin therapy in trabeculectomy","volume":"21","author":"Cobb","year":"2007","journal-title":"Eye (Lond)"},{"key":"R38-20260624","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ajo.2007.12.007","article-title":"Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy","volume":"145","author":"Law","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R39-20260624","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2147\/OPTH.S99746","article-title":"Ab interno trabeculectomy: Patient selection and perspectives","volume":"10","author":"Vinod","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R40-20260624","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bjophthalmol-2015-307131","article-title":"Review and meta-analysis of ab-interno trabeculectomy outcomes","volume":"100","author":"Kaplowitz","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R41-20260624","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2013.11.001","article-title":"Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: Technique report and preliminary results","volume":"121","author":"Grover","year":"2014","journal-title":"Ophthalmology"},{"key":"R42-20260624","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ophtha.2016.06.032","article-title":"Two-year COMPASS trial results: Supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts","volume":"123","author":"Vold","year":"2016","journal-title":"Ophthalmology"},{"key":"R43-20260624","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/IJG.0000000000000802","article-title":"Surgical outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with open-angle glaucoma","volume":"26","author":"Rahmatnejad","year":"2017","journal-title":"J Glaucoma"},{"key":"R44-20260624","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2017.07.023","article-title":"Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months","volume":"183","author":"Grover","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R45-20260624","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/IJG.0000000000001045","article-title":"Prospective evaluation of XEN Gel implant in eyes with pseudoexfoliative glaucoma","volume":"27","author":"Mansouri","year":"2018","journal-title":"J Glaucoma"},{"key":"R46-20260624","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ophtha.2018.05.012","article-title":"A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: The HORIZON study","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"R47-20260624","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/112067219500500106","article-title":"Contact transscleral cyclophotocoagulation with diode laser in refractory glaucoma","volume":"5","author":"Brancato","year":"1995","journal-title":"Eur J Ophthalmol"},{"key":"R48-20260624","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0161-6420(97)30109-2","article-title":"Cyclodiode. Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma","volume":"104","author":"Bloom","year":"1997","journal-title":"Ophthalmology"},{"key":"R49-20260624","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0161-6420(96)30508-3","article-title":"Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The diode laser ciliary ablation study group","volume":"103","author":"Kosoko","year":"1996","journal-title":"Ophthalmology"},{"key":"R50-20260624","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/IJG.0000000000000715","article-title":"Micropulse cyclophotocoagulation: Initial results in refractory glaucoma","volume":"26","author":"Emanuel","year":"2017","journal-title":"J Glaucoma"},{"key":"R51-20260624","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jamaophthalmol.2013.1642","article-title":"Anterior chamber bleeding after laser peripheral iridotomy","volume":"131","author":"Golan","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R52-20260624","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ogla.2019.05.002","article-title":"Effect of anticoagulants and surgeon-related factors on short-term outcomes of laser peripheral iridotomy","volume":"2","author":"Sanvicente","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"R53-20260624","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/08820538.2017.1353828","article-title":"Anticoagulation in glaucoma surgery","volume":"33","author":"Rahman","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"R54-20260624","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00417-008-0792-9","article-title":"Anticoagulation therapy in glaucoma surgery","volume":"246","author":"Alwitry","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R55-20260624","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S0004-27492013000600009","article-title":"Perioperative management of anticoagulant users scheduled for glaucoma surgery: A survey among the Brazilian glaucoma society members","volume":"76","author":"Balbino","year":"2013","journal-title":"Arq Bras Oftalmol"},{"key":"R56-20260624","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/bjophthalmol-2014-306036","article-title":"Ophthalmic patients on antithrombotic drugs: A review and guide to perioperative management","volume":"99","author":"Kong","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R57-20260624","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/bjophthalmol-2014-304902","article-title":"Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery","volume":"98","author":"Kiire","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R59-20260624","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s40140-021-00511-z","article-title":"Perioperative guidelines on antiplatelet and anticoagulant agents: 2022 update","volume":"12","author":"Moster","year":"2022","journal-title":"Curr Anesthesiol Rep"},{"key":"R60-20260624","first-page":"320","article-title":"Perioperative evaluation and optimization of patients at risk of cardiac complications for non-cardiac surgery","volume":"113","author":"Sweitzer","year":"2016","journal-title":"Mo Med"},{"key":"R61-20260624","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"key":"R62-20260624","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaophthalmol.2015.0985","article-title":"Risk of substantial intraocular bleeding with novel oral anticoagulants: Systematic review and meta-analysis","volume":"133","author":"Caldeira","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R63-20260624","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/eye.1993.174","article-title":"Management of the anticoagulated patient for ophthalmic surgery","volume":"7","author":"McCormack","year":"1993","journal-title":"Eye (Lond)"},{"key":"R64-20260624","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1742-1241.2010.02538.x","article-title":"Peri-operative management of ophthalmic patients taking antithrombotic therapy: Antithrombotic therapy in ophthalmic patients","volume":"65","author":"Lip","year":"2011","journal-title":"Int J Clin Pract"},{"key":"R65-20260624","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00417-017-3897-1","article-title":"Antiplatelet and anticoagulant agents in vitreoretinal surgery: A prospective multicenter study involving 804 patients","volume":"256","author":"Meillon","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_215_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:24:32Z","timestamp":1787747072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_215_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_215_24","relation":{},"ISSN":["0974-620X","0974-7842"],"issn-type":[{"value":"0974-620X","type":"print"},{"value":"0974-7842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2024-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}